Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 10,102 $ 7,253
Restricted cash 35 34
Accounts receivable, net of allowance of $478 and $647 at June 30, 2023 and December 31, 2022, respectively 22,790 46,565
Inventory 10,592 18,556
Prepaid expenses and other current assets 16,159 17,289
Assets held for sale – current 15,352
Total current assets 75,030 89,697
Property, plant and equipment, net 5,686 7,351
Goodwill 13,641
Intangible assets, net 5,302
Right-of-use assets, net 3,711 5,697
Other non-current assets 3,059 3,407
Assets held for sale – non-current 20,913
Total assets 108,399 125,095
Current liabilities:    
Accounts payable 17,393 26,173
Accrued expenses and other current liabilities 31,247 32,243
Deferred revenue 1,547 2,892
Senior term loan, current portion 4,179 40,529
Subordinated debt 11,396 11,119
Subordinated term loan – related party 41,528
Convertible debt 43,928
Current portion of long-term debt 265 259
Liabilities held for sale – current 12,015
Total current liabilities 78,042 198,671
Subordinated term loan – related party 43,402
Senior term loan 59,045
Convertible debt 47,749
Other long-term liabilities 9,561 7,223
Liabilities held for sale – non-current 375
Total liabilities 238,174 205,894
Stockholders’ deficit:    
Common stock, $0.0001 par value; 250,000,000 shares authorized; 74,582,992 and 74,283,026 shares issued and outstanding at both June 30, 2023 and December 31, 2022 7 7
Additional paid-in capital 775,947 770,427
Accumulated deficit (905,729) (851,233)
Total stockholders’ deficit (129,775) (80,799)
Total liabilities and stockholders’ deficit $ 108,399 $ 125,095